
Leading a neuroscience startup that uses AI to decode the human brain by mapping brain connections, receiving $20 million investment from NRF.
How media typically covers Stephen Scheeler
Referenced in coverage
Omniscient Neurotechnology secures $20 million Series D funding to scale its AI-powered brain-mapping platform (Quicktome) that personalizes neurosurgical treatment plans using MRI analysis.
“Leading a neuroscience startup that uses AI to decode the human brain by mapping brain connections, receiving $20 million investment from NRF.”